Target Information

Phenna Group, headquartered in Nottingham, UK, is focused on investing in and partnering with niche, independent Testing, Inspection, Certification and Compliance (TICC) companies across various sectors. Its goal is to provide customers with exceptional assurance services, enhancing confidence in the products and services being tested. This partnership marks Phenna Group's inaugural entry into the food and health sciences market, further diversifying and strengthening its TICC portfolio.

Complete Laboratory Solutions (CLS), established in 1994 and based in Galway, is the largest privately owned contract laboratory in Ireland. The company specializes in microbiological and chemical testing services, and it provides trained, industry-ready laboratory analysts to clients on a contract basis. With two accredited facilities located in Galway City and Ros Muc, and a newly opened third facility in Bray, Co Wicklow, CLS serves clients across multiple sectors, including food, water, environmental, pharmaceutical, medical devices, and clinical research. The organization holds several important accreditations, including ISO 9001, ISO 17025 (108T), ISO 15189 (400MT), and is GMP licensed by the Health Products Regulatory Authority (HPRA) as well as the U.S. Food and Drug Administration (FDA).

Industry Overview

The laboratory services industry in Ireland has been witnessing significant growth, driven by the increasing demand for rigorous testing standards across various sectors. The healthcare sector, particularly, has seen a surge in investment due to heightened regulatory requirements and consumer demand for quality assurance in food and health products. Companies in this sector are striving to comply with international standards in testing and certification, thereby enhancing their competitive edge.

Furthermore, the food and pharmaceutical industries are evolving rapidly, requiring sophisticated laboratory services to ensure safety and compliance. The integration of advanced technologies in testing and certification processes is paramount for providers looking to meet these growing demands. This creates a favorable environment for companies like CLS, which possess a strong track record and extensive capabilities in the laboratory services space.

Additionally, Ireland is strategically positioned as a hub for biotechnology and pharmaceutical industries, attracting considerable investment and talent. The government's support for the sector through favorable policies and funding initiatives further enhances the landscape for laboratory service providers. This industry momentum offers significant opportunities for acquisitions and partnerships among testing laboratories.

In summary, the laboratory testing and certification landscape in Ireland is dynamic, with increasing emphasis on quality, compliance, and technological advancements. Companies like CLS, with their extensive accreditation and experience, are well-placed to leverage these opportunities for growth.

Rationale Behind the Deal

Phenna Group's decision to partner with CLS stems from a strategic desire to expand its market presence in the food and health sciences sector. By acquiring CLS, Phenna Group aims to leverage its established reputation and broad client base to enhance its service offerings. The synergies created by this partnership are expected to drive innovation and improve the efficiency of services provided, ultimately benefiting both companies and their clients.

Furthermore, the deal enables Phenna Group to tap into CLS's extensive experience and industry knowledge, allowing for a smoother integration and expansion process. This collaboration is anticipated to foster growth in revenue and profitability while delivering exceptional quality assurance services to clients in the food and healthcare markets.

Investor Information

Phenna Group is recognized for its strategic acquisitions and partnerships that enrich its portfolio of TICC companies. The Group operates across several sectors and has demonstrated a commitment to expanding its influence by seeking high-performing entities that align with its vision and values. Led by Group CEO Paul Barry, Phenna Group is noted for its rapid growth and focus on operational excellence.

Under Paul Barry's leadership, Phenna Group is determined to uphold its high standards while fostering the development of its partner companies. The collaboration with CLS exemplifies Barrett’s commitment to building a diverse and multifaceted group capable of delivering first-class services in vital markets. The Group's strategic vision positions it to capitalize on the increasing demand for robust testing and certification services in various industries.

View of Dealert

This transaction presents a promising investment opportunity for Phenna Group. The acquisition of CLS aligns well with the Group’s strategic objectives, particularly its expansion into the food and health sciences markets. CLS's established reputation and regulatory accreditations significantly enhance Phenna Group's ability to compete in these vital sectors.

Moreover, CLS's strong operational framework and comprehensive service offerings create a solid foundation for growth. By integrating CLS into its existing network, Phenna Group can capitalize on cross-selling opportunities and optimize resource utilization. This partnership not only augments Phenna’s service capabilities but also enhances its value proposition from a client perspective.

Furthermore, the current trajectory of the laboratory services industry in Ireland suggests that CLS's market offerings will remain in high demand. As compliance requirements become more stringent, the need for reliable laboratory services is likely to rise, ensuring steady revenue growth for the combined entity.

In conclusion, this partnership is poised to be a strong strategic move for Phenna Group, with robust prospects for growth and innovation within the food and health sciences sectors. If effectively leveraged, this investment could yield significant returns and position Phenna Group as a leader in the TICC arena.

View Original Article

Similar Deals

Innovize and Excel Scientific Zenith Adhesive Components

2022

Platform Acquisition Healthcare Providers & Services Ireland
H2 Equity Partners Healthcare 21 Group and Aquilant

2018

Platform Acquisition Healthcare Providers & Services Ireland
Health Catalyst, Inc. Upfront Healthcare Services, Inc.

2025

Platform Acquisition Healthcare Providers & Services United States of America
Berkshire Partners Forcura and Medalogix

2025

Platform Acquisition Healthcare Providers & Services United States of America
Integrated Foot and Ankle Specialists Comprehensive Foot & Ankle Center of South Jersey

2025

Platform Acquisition Healthcare Providers & Services United States of America
HitecVision and Reinova Partners Greencoat Renewables plc

2025

Platform Acquisition Renewable Energy Ireland
Health Assurance Transformation Company (HATCo) Summa Health

2025

Platform Acquisition Healthcare Providers & Services United States of America
Proclinic Group Cenger Scandinavia

2025

Platform Acquisition Healthcare Providers & Services Denmark
Already Autism Health Commonwealth ABA

2025

Platform Acquisition Healthcare Providers & Services United States of America
Calibre Scientific DCS Innovative Diagnostik-Systeme GmbH & Co. KG

2024

Platform Acquisition Healthcare Providers & Services Germany

Phenna Group

invested in

Complete Laboratory Solutions

in

in a Platform Acquisition deal

Deal Parametres
Industry
Country
Seller type

Sign Up to Dealert